Dr. Deborah COHEN Associate Editor, British Medical Journal, London
CV
1997-2003 | Medicine & French, Manchester University, Manchester |
2005-2006 | Analysis Editor, The British Medical Journal, London |
2006-2010 | Features and Debates Editor, The British Medical Journal, London |
2010-2015 | Investgations Editor, The British Medical Journal, London |
since 2015 | Freelance Broadcast Journalist, London |
Publikationen
Cohen D., Why have UK doctors been prevented from prescribing Avastin? BMJ 350:h1654, 2015 | |
Cohen D., Dabigatran: How the Drug Company withheld important Analyses BMJ 49:g4670, 2014 | |
Cohen D., Concerns over key data in dabigatran trial. BMJ 349:g4747, 2014 | |
Cohen D., Raftery J. Paying twice: questions over high cost of cystic fibrosis drug developed with charitable funding. BMJ 348:g1445, 2014 | |
Cohen D., FDA official: "clinical trial system is broken". BMJ ;347:f6980, 2013 | |
Cohen D., Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed? BMJ; 346:f3680, 2013 |